Biophytis (EPA:ALBPS) | WebDisclosure

PRESS RELEASE

published on 10/30/2025 at 22:59, 7 months 23 days ago

Biophytis Reports First-Half 2025 Results and Provides Strategic Update
Biophytis reports financial results for the first half of 2025, strategic update, and key achievements in sarcopenia and obesity. Plans for Phase 2 and Phase 3 studies outlined with focus on sustaining growth and value creation

Financial Results Biophytis Sarcopenia Strategic Update Obesity
BRIEF

published on 10/13/2025 at 07:05, 8 months 10 days ago

Biophytis et Partenaires Asiatiques Lancent un Essai Clinique Historique

Biophytis Essai Clinique Sarcopénie BIO101 Coentreprise Hong Kong
BRIEF

published on 10/13/2025 at 07:05, 8 months 10 days ago

Biophytis and Asian Investors to Launch Phase 3 Sarcopenia Trial

Biophytis Phase 3 Trial Sarcopenia BIO101 Asian Investors
REGULATED PRESS RELEASE

published on 10/13/2025 at 07:00, 8 months 10 days ago

BIOPHYTIS et un consortium d’investisseurs incluant RONGHUI RENHE Life Technology unissent leurs forces pour financer et lancer le tout premier essai clinique de Phase 3 dans la sarcopénie
BIOPHYTIS et un consortium d'investisseurs lancent le premier essai clinique de Phase 3 dans la sarcopénie, avec une coentreprise à Hong Kong et un investissement de 20 M$. Opérations cliniques prévues début 2026

Biophytis Investisseurs Essai Clinique Coentreprise Sarcopénie
REGULATED PRESS RELEASE

published on 10/13/2025 at 07:00, 8 months 10 days ago

BIOPHYTIS and a Consortium of Investors including RONGHUI RENHE Life Technology Join Forces to Finance and Launch First-Ever Phase 3 Trial in Sarcopenia
BIOPHYTIS and a Consortium of Investors partner to finance and launch Phase 3 Trial in Sarcopenia, creating a joint venture in Hong Kong with US$20 million investment for clinical operations starting early 2026

Biophytis Joint Venture Phase 3 Trial Sarcopenia Consortium Of Investors
PRESS RELEASE

published on 10/13/2025 at 06:59, 8 months 10 days ago

BIOPHYTIS et un consortium d’investisseurs incluant RONGHUI RENHE Life Technology unissent leurs forces pour financer et lancer le tout premier essai clinique de Phase 3 dans la sarcopénie
Biophytis et un consortium d'investisseurs, dont Ronghui Renhe Life Technology, s'unissent pour lancer l'essai clinique de Phase 3 en sarcopénie, avec une coentreprise à Hong-Kong

Biophytis Essai Clinique Coentreprise Sarcopénie Consortium D'investisseurs
BRIEF

published on 09/30/2025 at 07:05, 8 months 23 days ago

Biophytis Renforce Sa Présence sur la Scène Internationale au 4ème Trimestre 2025

Biophytis Partenariats Sarcopénie Biotechnologies Événements Internationaux
BRIEF

published on 09/30/2025 at 07:05, 8 months 23 days ago

Biophytis to Engage in Key Events in Q4 2025

Biophytis Partnerships Longevity Sarcopenia Biotechnology Events
REGULATED PRESS RELEASE

published on 09/30/2025 at 07:00, 8 months 23 days ago

Biophytis to Participate in Four Key Events in Q4 2025
Biophytis to participate in four major international events in Q4 2025, showcasing its progress in transformative therapies impacting longevity and seeking new partnerships

Biophytis Partnerships Longevity International Events Transformative Therapies
REGULATED PRESS RELEASE

published on 09/30/2025 at 07:00, 8 months 23 days ago

Biophytis annonce sa participation à quatre événements clés au cours du 4ème trimestre 2025
Biophytis annonce sa participation à quatre événements clés internationaux au 4ème trimestre 2025 pour présenter ses avancées dans la santé et renforcer ses partenariats

Biophytis Développement Participation Événements Clés 4ème Trimestre 2025

Published on 06/23/2026 at 13:00, 30 minutes ago

AI/ML Innovations Inc. Announces Grant of U.S. Patent Expanding Protection for AI-Driven ECG Analysis
Published on 06/23/2026 at 13:00, 30 minutes ago

Azarga Metals 2026 Marg Project Drill Program; Keno Hill District, Yukon
Published on 06/23/2026 at 13:00, 30 minutes ago

Gold Terra Announces 5.88 g/t Gold over 19.00 Metres Including 18.50 g/t Gold over 4.0 Metres in the Yellorex Area, Con Mine Option Property, Yellowknife, NWT
Published on 06/23/2026 at 13:00, 30 minutes ago

Aclara Receives Positive Environmental Qualification Resolution For The Penco Module
Published on 06/23/2026 at 09:05, 4 hours 25 minutes ago

Star Copper Extends Copper Creek Drill Hole Beyond Planned Depth After Intersecting Mineralized System

View all ACCESSWIRE

Published on 06/23/2026 at 13:04, 25 minutes ago

Blue Cap AG: Annual General Meeting Approves Record Dividend of EUR 1.60 per Share
Published on 06/23/2026 at 12:25, 1 hour 4 minutes ago

Fair Play Menarini International Award
Published on 06/23/2026 at 12:15, 1 hour 14 minutes ago

Thailand Launches FastPass Program, Unlocking USD 21 billion in Strategic High-Tech Investment
Published on 06/23/2026 at 11:42, 1 hour 47 minutes ago

Original-Research: Daldrup & Söhne AG (von Quirin Privatbank Kapitalmarktgeschäft): Buy
Published on 06/23/2026 at 11:30, 1 hour 59 minutes ago

Hoymiles Unveils HiBattery 4020 Series at "The Unbreakable Night" Event in Munich

View all EQS

Published on 06/22/2026 at 18:45, 18 hours 45 minutes ago

Governance evolution
Published on 06/22/2026 at 18:45, 18 hours 45 minutes ago

ÉVOLUTION DE LA GOUVERNANCE
Published on 06/22/2026 at 18:16, 19 hours 13 minutes ago

ANTOINE FREY INCREASES HIS STAKE IN FREY
Published on 06/22/2026 at 18:16, 19 hours 13 minutes ago

ANTOINE FREY SE RENFORCE AU CAPITAL DE FREY
Published on 06/22/2026 at 18:00, 19 hours 30 minutes ago

GUILLEMOT CORPORATION : DECES DE M. CLAUDE GUILLEMOT, Président du Groupe GUILLEMOT CORPORATION

View all LES ECHOS COMFI WIRE

News